New study tracks men with lichen sclerosus for 10 years to uncover best treatments
NCT ID NCT06984263
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will follow 300 men diagnosed with lichen sclerosus, a chronic skin condition affecting the genitals, for up to 10 years. Researchers will track how well routine treatments like circumcision work, monitor for disease recurrence or complications, and assess the impact on quality of life and sexual health. The goal is to identify risk factors and improve long-term care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could provide a clearer understanding of how lichen sclerosus progresses and what treatments work best, potentially improving care guidelines.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by the specific population in one region of Sweden.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LICHEN SCLEROSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Umeå University Hospital
RECRUITINGUmeå, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••